Business / Finance

RSS

Premier healthcare alliance named one of World's Most Ethical Companies for 2011

The Premier healthcare alliance has been named one of the Ethisphere Institute's 2011 World's Most Ethical Companies for the fourth year in a row. Ethisphere selected Premier from a record number of applicants across the globe.

21 Mar 2011

Sarsia Seed provides follow-up funding for APIM Therapeutics

APIM Therapeutics AS, an early-stage Norwegian therapeutic company, is pursuing a novel drug approach with the ability to potentiate the action of a wide range of chemotherapeutic drugs currently used to treat several types of cancer.

21 Mar 2011

AOBO board announces $20 million share buyback program

American Oriental Bioengineering, Inc., a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, announced at its 2010 earnings conference call, held on March 15, 2011, that its board of directors authorized a share buyback program for the repurchase of up to $20 million of the Company's outstanding common stock over the next two years.

21 Mar 2011

CardioFocus secures $5M in debt financing from Silicon Valley Bank

CardioFocus, a venture capital-backed medical device company developing technology to treat cardiac disorders, has secured $5M in debt financing from Silicon Valley Bank, financial partner to technology and life science companies of all sizes worldwide. CardioFocus will use the new financing to initiate its pivotal trial in the United States and to expand the commercialization of its products in Europe.

21 Mar 2011

LTC declares $0.50 per share quarterly dividend on Series F Cumulative Preferred Stock

LTC Properties, Inc. announced today that it had declared the quarterly cash dividend of $0.50 per share on the Company's 8.0% Series F Cumulative Preferred Stock. The dividend is payable on April 15, 2011 to stockholders of record on April 1, 2011.

21 Mar 2011

Teleflex retires all of the 2004 senior notes

Teleflex Incorporated announced today that on March 16, 2011 it prepaid the remaining $64.0 million in aggregate principal amount of its 2004 senior notes. This consisted of $26.75 million of 6.66% senior notes due in 2011, $21.75 million of 7.14% senior notes due in 2014, and $15.5 million of 7.46% senior notes due in 2016, which completely retired all of the 2004 senior notes.

21 Mar 2011

Anacor enters $30 million loan agreement

Anacor Pharmaceuticals announced today that it has entered into a loan agreement led by Oxford Finance Corporation and partnered with Horizon Technology Finance Corporation to provide up to $30 million in capital. Anacor used $6.6 million to repay the remaining obligations under its loan agreement with Lighthouse Capital Partners and expects to use the remainder of the capital to fund development activities related to AN2690, AN2728 and AN2898.

21 Mar 2011

ACS announces definitive agreement to acquire CredenceHealth

Affiliated Computer Services, Inc. (ACS), A Xerox Company, today announced a definitive agreement to acquire CredenceHealth, Inc., creating a simple way for healthcare providers to use patient information to predict and prevent complications.

21 Mar 2011

Feihe fourth quarter revenues increased 41.6% to $62.3 million

Feihe International, Inc., one of the leading producers and distributors of premium infant formula, milk powder and soybean, rice and walnut products in China, today announced unaudited financial results for the fourth quarter and full year ended December 31, 2010.

21 Mar 2011

Insmed regains compliance with NASDAQ minimum bid price rule

Insmed Incorporated, a biopharmaceutical company, today announced that it has received notification from The NASDAQ Stock Market that it has regained compliance with the minimum $1.00 per share bid price requirement.

21 Mar 2011

Hi-Tech Pharmacal acquires rights to Nystatin Oral suspension ANDA from Bausch + Lomb

Hi-Tech Pharmacal Co., Inc. announced that it has acquired the rights to the Abbreviated New Drug Application (ANDA) for Nystatin Oral suspension from Bausch + Lomb, the global eye health company for an undisclosed upfront payment and a future royalty.

21 Mar 2011

Echo Therapeutics fiscal 2010 net loss decreases to $4.1 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced results for the year ended December 31, 2010.

21 Mar 2011

Synageva BioPharma closes $25 million private equity financing

Synageva BioPharma Corp., a privately held biopharmaceutical company developing therapeutic products for rare disorders, announced today the closing of a $25 million private equity financing.

21 Mar 2011

Quest Diagnostics proposes $1,250,000,000 senior notes offering

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced today that it intends to offer $1,250,000,000 in aggregate principal amount of four series of senior notes in a public offering made under a shelf registration statement filed with the Securities and Exchange Commission, subject to market and other conditions.

From Quest Diagnostics 21 Mar 2011

Investissement Québec provides financial support to Algorithme Pharma

Algorithme Pharma Inc., a Canadian clinical contract research organization, with facilities in Laval Québec, Montréal Québec, and through its sister company Simbec Research Limited in Merthyr Tydfil UK, today announced having secured the support of Investissement Québec in the form of a loan.

21 Mar 2011

Advanced Cell Technology reduces 2010 debt to less than $1 million

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today 2010 year-end results for the period ended December 31, 2010. The Company utilized $8.8 million in cash for operations during the year, compared to $5.1 million in the year-earlier period.

21 Mar 2011